Inclusion Criteria:  Adult patients, 18 years and above SARS-2-CoV-2 infection, laboratory-confirmed Admission to the hospital ward or ICU Written informed consent prior to initiation of the study or a close relative/legal representative provides written informed consent prior to initiation of the study according to the presumed will of the patient when the patient is unable to give consent herself/himself. No anticipated transfer within 72 hours to a non-study hospital  Exclusion Criteria:  Estimated life expectancy under three months due to severe comorbidity ASAT/ALAT-ratio over five-fold upper limit Acute myocardial infarction or unstable angina pectoris Breast feeding or pregnancy Any reason why, in the opinion of the investigators, the patient should not participate Patient participates in a potentially confounding drug or device trial during the course of the study Already receiving any of the study drugs Severe renal failure (eGFR < 30 mL/min)